Adaptimmune Therapeutics plc ADAP NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • GB • USD

SharesGrow Score

52/100

3/7 Pass

SharesGrow Intrinsic Value

Adaptimmune Therapeutics plc (ADAP) has 20 既知のインサイダーおよび機関投資家保有者の記録. 最大保有者は EcoR1 Capital, LLC 164,424,420 株保有. その他の主要保有者には BARRETT M JAMES および KERINS PATRICK J.

ADAP インサイダー保有状況

最大保有者

EcoR1 Capital, LLC

164,424,420 株

買い（12ヶ月）

$0.00 評価額

売り（12ヶ月）

$0.00 評価額

インサイダー上位保有者

#	氏名	役職	保有株数	最終申告日	相対規模
1	Ecor1 Capital, Llc	10 Percent Owner	164,424,420	2024-03-26	100%
2	Barrett M James	10 Percent Owner	82,978,668	2018-09-10	50%
3	Kerins Patrick J	10 Percent Owner	82,978,668	2018-09-10	50%
4	New Enterprise Associates 14, L.p.	10 Percent Owner	82,978,668	2018-09-10	50%
5	Weller Harry R	10 Percent Owner	59,269,000	2016-01-04	36%
6	Kolluri Krishna Kittu	10 Percent Owner	59,269,000	2016-01-04	36%
7	Baskett Forest	10 Percent Owner	19,500,000	2020-01-28	12%
8	Florence Anthony A. Jr.	10 Percent Owner	19,500,000	2020-01-28	12%
9	Sandell Scott D	10 Percent Owner	19,500,000	2020-01-28	12%
10	Sonsini Peter W.	10 Percent Owner	19,500,000	2020-01-28	12%
11	Barris Peter J	10 Percent Owner	12,000,000	2018-09-10	7%
12	Viswanathan Ravi	10 Percent Owner	12,000,000	2018-09-10	7%
13	Thompson Peter A.	Director	4,902,910	2018-06-06	3%
14	Orbimed Advisors Llc	Director	4,902,910	2018-06-06	3%
15	Rawcliffe Adrian	Chief Executive Officer	3,428,832	2025-02-20	2%
16	Mott David M	Director	1,583,214	2024-07-01	1%
17	Alleva Lawrence M	Director	1,213,926	2024-07-01	1%
18	Behbahani Ali	Director	1,144,686	2024-07-01	1%
19	Hegde Priti	Director	1,144,686	2024-07-01	1%
20	Menzel Garry E	Director	1,121,604	2024-07-01	1%